Cardiovascular registry research comes of age

Heart

Volumn 96, Issue 12, 2010, Pages 908-910

  McNamara, Robert L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; EDITORIAL; EXTERNAL VALIDITY; FOLLOW UP; HUMAN; INFORMATION SYSTEM; KNOWLEDGE; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; REGISTER; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE CORONARY SYNDROME; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; HUMANS; REGISTRIES;

EID: 77953710667     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.198069     Document Type: Editorial

References (15)

1. Alpert JS. Are data from clinical trials of any value? Eur Heart J 2000;21:1399-401.
2. Gitt AK, Bueno H, Danchin N, et al. The role of cardiac registries in evidence-based medicine. Eur Heart J 2010;31:520-1.
3. Granger CB, Steg PG, Peterson E, et al. GRACE investigators. Medication performance measures and mortality following acute coronary syndromes. Am J Med 1005;118:858-65.
4. McNamara RL, Herrin J, Bradley EH, et al. Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999-2002. J Am Coll Cardiol 2006;47:45-7.
5. Tickoo S, Roe MT, Peterson ED, et al. Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE quality improvement initiative. Am J Cardiol 2007;99:1496-9.
6. Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acute myocardial infarction: correlation among hospital measures and relationship with short-term mortality. JAMA 2006;296:72-8.
7. Barron HV, Michaels AD, Maynard C. Every NR. Use of angiotensin- converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 1998;32:360-7.
8. Rogers W, Canto J, Lambrew C, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000;36:2056-63.
9. Jha P, Deboer D, Sykora K, et al. Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison. J Am Coll Cardiol 1996;27:1335-42.
10. Steg PG, Lopez-Sendon J, Lopez de SE, et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007;167:68-73.
11. Zahn R, Gottwik M, Hochadel M, et al. Interventional cardiology: volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the registry of percutaneous coronary interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Heart 2008;94:329-35.
12. Patrignani P, Capone ML, Tacconelli S. NSAIDs and cardiovascular disease. Heart 2008;94:395-7.
13. Ryan JW, Peterson ED, Chen AY, et al. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry. Circulation 2005;112:3049-57.
14. Ferreira-González F, Marsal JR, Mitjavila F, et al. Patient registries of acute coronary syndrome: assessing or biasing the clinical real world data? Circ Cardiovasc Qual Outcomes 2009;2:540-7.
15. Krumholz HM. Registries and selection bias. The need for accountability. Circ Cardiovasc Qual Outcomes 2009;2:517-18.